• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗专家对多发性硬化症患者的手术治疗方法。

Iranian specialists' approach to surgery in patients with multiple sclerosis.

作者信息

Ghadiri Fereshteh, Ebadi Zahra, Asadollahzadeh Elnaz, Sahraian Mohammad Ali, Azimi Amirreza, Navardi Samira, Heidari Hora, Abna Zohreh, Aboutorabi Marzieh, Adibi Iman, Baghbanian Seyed Mohammad, Paybast Sepideh, Poursadeghfard Maryam, Hosseini Samaneh, Shahmohammadi Sareh, Ghaffari Mehran, Ghalyanchi-Langroodi Hamidreza, Ghiasian Masoud, Kamali Hoda, Kouchaki Ebrahim, Mahrabi Farzad, Mohammadianinejad Ehsan, Nahayati Mohammad Ali, Moghadasi Abdorreza Naser

机构信息

Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

Department of Neurology, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

出版信息

Curr J Neurol. 2023 Apr 4;22(2):96-102. doi: 10.18502/cjn.v22i2.13336.

DOI:10.18502/cjn.v22i2.13336
PMID:38011379
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10460921/
Abstract

Data on perioperative risk stratification in patients with multiple sclerosis (MS) are limited. In this regard, the present study was conducted to investigate Iranian specialists' approach to surgical counseling for patients with MS (PwMS). 21 MS specialists were asked about 11 case scenarios with different MS disease statuses, disease-modifying therapies (DMTs), and urgency of the operation. The reasons for refusing surgery or factors that have to be considered before surgery were studied. Overall, Fleiss Kappa was estimated to be 0.091 [95% confidence interval (CI): 0.090-0.093, P < 0.001] indicating a very poor level of agreement among responders. PwMS face surgery for various reasons. Risk assessment of surgery, the effect of various drugs such as anesthetics and DMT on patients, as well as many other aspects of MS are issues challenging the practitioners. Clarifying the various dimensions of these issues requires further research.

摘要

关于多发性硬化症(MS)患者围手术期风险分层的数据有限。在这方面,本研究旨在调查伊朗专家对MS患者(PwMS)进行手术咨询的方法。向21名MS专家询问了11种具有不同MS疾病状态、疾病修饰疗法(DMT)和手术紧迫性的病例情况。研究了拒绝手术的原因或手术前必须考虑的因素。总体而言,Fleiss Kappa估计为0.091[95%置信区间(CI):0.090 - 0.093,P < 0.001],表明应答者之间的一致性水平非常低。PwMS因各种原因接受手术。手术风险评估、麻醉剂和DMT等各种药物对患者的影响以及MS的许多其他方面都是困扰从业者的问题。阐明这些问题的各个方面需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c3/10460921/43b990db022e/CJN-22-96-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c3/10460921/43b990db022e/CJN-22-96-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c3/10460921/43b990db022e/CJN-22-96-g001.jpg

相似文献

1
Iranian specialists' approach to surgery in patients with multiple sclerosis.伊朗专家对多发性硬化症患者的手术治疗方法。
Curr J Neurol. 2023 Apr 4;22(2):96-102. doi: 10.18502/cjn.v22i2.13336.
2
Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment.伊朗专家对认知障碍多发性硬化症患者治疗升级的处理方法。
Curr J Neurol. 2023 Jan 5;22(1):1-7. doi: 10.18502/cjn.v22i1.12610.
3
Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden.瑞典1923例多发性硬化症患者的疾病改善治疗轨迹及相关病假和残疾抚恤金情况
Mult Scler Relat Disord. 2023 Jan;69:104456. doi: 10.1016/j.msard.2022.104456. Epub 2022 Dec 9.
4
Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis.与其他用于治疗多发性硬化症的疾病修正疗法相比,奥瑞珠单抗相关的工作生产力结果。
Neurol Ther. 2021 Jun;10(1):183-196. doi: 10.1007/s40120-020-00224-1. Epub 2020 Nov 26.
5
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.多发性硬化症患者感染 COVID-19 的风险:一项病例对照研究。
Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2). doi: 10.1212/NXI.0000000000001141. Print 2022 Mar.
6
Factors influencing patients' willingness-to-pay for disease-modifying therapies for multiple sclerosis.影响患者对多发性硬化症疾病修正疗法支付意愿的因素。
Mult Scler Relat Disord. 2021 Feb;48:102720. doi: 10.1016/j.msard.2020.102720. Epub 2020 Dec 24.
7
The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study.疾病改善治疗获取障碍对多发性硬化症患者的影响:混合方法研究
J Med Internet Res. 2018 Oct 30;20(10):e11168. doi: 10.2196/11168.
8
Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years.加拿大不列颠哥伦比亚省新的多发性硬化症口服疾病修正疗法的使用:头五年。
Mult Scler Relat Disord. 2018 Oct;25:57-60. doi: 10.1016/j.msard.2018.07.012. Epub 2018 Jul 9.
9
Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series.干细胞治疗后多发性硬化症的疾病修正治疗管理:回顾性病例系列。
Mult Scler Relat Disord. 2022 Jul;63:103861. doi: 10.1016/j.msard.2022.103861. Epub 2022 May 10.
10
Patients experiences with multiple sclerosis disease-modifying therapies in daily life - a qualitative interview study.患者在日常生活中对多发性硬化症治疗药物的体验——一项定性访谈研究。
BMC Health Serv Res. 2021 Oct 22;21(1):1141. doi: 10.1186/s12913-021-07012-z.

本文引用的文献

1
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.预测奥瑞珠单抗治疗多发性硬化症患者的感染风险:一项回顾性队列研究。
CNS Drugs. 2021 Aug;35(8):907-918. doi: 10.1007/s40263-021-00810-3. Epub 2021 Apr 13.
2
Bariatric and metabolic surgery in patients with morbid obesity and multiple sclerosis - a nationwide, matched cohort study.病态肥胖和多发性硬化症患者的减肥和代谢手术 - 一项全国性匹配队列研究。
Surg Obes Relat Dis. 2021 Jun;17(6):1108-1114. doi: 10.1016/j.soard.2021.02.013. Epub 2021 Feb 17.
3
Global incidence of surgical site infection after appendectomy: a systematic review and meta-analysis.
全球阑尾切除术术后手术部位感染发生率:系统评价和荟萃分析。
BMJ Open. 2020 Feb 18;10(2):e034266. doi: 10.1136/bmjopen-2019-034266.
4
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines.多发性硬化症诊断与治疗的共识建议:2019 年 MENACTRIMS 指南修订版。
Mult Scler Relat Disord. 2020 Jan;37:101459. doi: 10.1016/j.msard.2019.101459. Epub 2019 Oct 18.
5
Multiple sclerosis relapse risk in the postoperative period: Effects of invasive surgery and anesthesia.术后多发性硬化症复发风险:侵袭性手术和麻醉的影响。
Mult Scler. 2020 Oct;26(11):1437-1440. doi: 10.1177/1352458519860304. Epub 2019 Jun 25.
6
Surgical management of patients with coexistent multiple sclerosis and cervical stenosis: A systematic review and meta-analysis.合并多发性硬化症和颈椎管狭窄症患者的手术治疗:一项系统评价和荟萃分析。
J Clin Neurosci. 2019 Jul;65:77-82. doi: 10.1016/j.jocn.2019.04.001. Epub 2019 Apr 20.
7
Multiple sclerosis - a review.多发性硬化症——综述。
Eur J Neurol. 2019 Jan;26(1):27-40. doi: 10.1111/ene.13819. Epub 2018 Nov 18.
8
Multiple sclerosis: clinical aspects.多发性硬化症:临床方面。
Curr Opin Neurol. 2018 Dec;31(6):752-759. doi: 10.1097/WCO.0000000000000622.
9
Outcomes of Bariatric Surgery in Morbidly Obese Patients with Multiple Sclerosis.重度肥胖的多发性硬化症患者接受减肥手术的结果。
J Obes. 2017;2017:1935204. doi: 10.1155/2017/1935204. Epub 2017 Feb 19.
10
Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod.停用芬戈莫德后多发性硬化症患者的严重疾病加重
Neurol Neurochir Pol. 2017 Mar-Apr;51(2):156-162. doi: 10.1016/j.pjnns.2017.01.006. Epub 2017 Feb 2.